New #CommsMed paper: FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models. #DM1 #MyoBlue tinyurl.com/z4jrmaxk
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models - Communications Medicine
Weeden et al. use a method called FORCE to deliver oligonucleotides to muscle and evaluate the platform’s utility in models of myotonic dystrophy. An antisense oligonucleotide targeting DMPK is guided...
tinyurl.com
January 18, 2025 at 6:12 PM
New #CommsMed paper: FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models. #DM1 #MyoBlue tinyurl.com/z4jrmaxk
🎉Our new research in Communications Medicine shows #Tirzepatide & #Semaglutide deliver better ocular safety—fewer cataracts, dry-eye & visual problems—than traditional anti-obesity drugs. Read 👉 www.nature.com/commsmed
December 26, 2025 at 11:02 AM
🎉Our new research in Communications Medicine shows #Tirzepatide & #Semaglutide deliver better ocular safety—fewer cataracts, dry-eye & visual problems—than traditional anti-obesity drugs. Read 👉 www.nature.com/commsmed